Please wait while the formulary information is being retrieved.
KOURZEQ (triamcinolone acetonide)
- painful, red or swollen mouth
0.1 % dental paste
- Place a small amount to the affected area by mucous membrane route 2-3 times daily after meals
0.1 % dental paste
- Place a small amount to the affected area by mucous membrane route 2-3 times daily after meals
0.1 % dental paste
- Place a small amount to the affected area by mucous membrane route 2-3 times daily after meals
Default screening record
- Place a small amount to the affected area by mucous membrane route 2-3 times daily after meals
- Place a small amount to the affected area by mucous membrane route once daily at bedtime
- None
Contraindicated
- None
Severe
Moderate
- None
- Oral candidiasis
- Periodontal infection
Contraindicated
- None
Severe
Moderate
- Hypothalamic-pituitary insufficiency
KOURZEQ (triamcinolone acetonide)
- painful, red or swollen mouth
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Hyperglycemia
- Mouth irritation
- Peptic ulcer
Less Severe
- Dysgeusia
Contraindicated
None
Severe Precaution
Triamcinolone Acet (Top,Dental)
Limit use. May be more susceptible to topical steroid-induced HPA-Axis suppression.
- 1 Day – 13 Years
- Limit use. May be more susceptible to topical steroid-induced HPA-Axis suppression.
Management or Monitoring Precaution
None
Triamcinolone Acet (dental)
- Severity Level:
C
- Additional Notes: Systemic absorption unlikely;possible risk of orofacial clefts w/systemic use
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Triamcinolone Acet (dental)
Amount of systemic absorption unknown, caution advised.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Amount of systemic absorption unknown, caution advised. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Stomatitis | |
| K12.0 | Recurrent oral aphthae |
| K12.1 | Other forms of stomatitis |
| K12.3 | Oral mucositis (ulcerative) |
| K12.30 | Oral mucositis (ulcerative), unspecified |
| K12.31 | Oral mucositis (ulcerative) due to antineoplastic therapy |
| K12.32 | Oral mucositis (ulcerative) due to other drugs |
| K12.33 | Oral mucositis (ulcerative) due to radiation |
| K12.39 | Other oral mucositis (ulcerative) |
| 0-9 | A-Z |
|---|---|
| K12.0 | Recurrent oral aphthae |
| K12.1 | Other forms of stomatitis |
| K12.3 | Oral mucositis (ulcerative) |
| K12.30 | Oral mucositis (ulcerative), unspecified |
| K12.31 | Oral mucositis (ulcerative) due to antineoplastic therapy |
| K12.32 | Oral mucositis (ulcerative) due to other drugs |
| K12.33 | Oral mucositis (ulcerative) due to radiation |
| K12.39 | Other oral mucositis (ulcerative) |
Formulary Reference Tool